Danny Rischin, Sandro V. Porceddu, Fiona Day, Daniel Brungs, Hayden Robert Christie, James Estes Jackson, Brian N. Stein, Yungpo Su, Gerard Adams, Samantha Bowyer, Zulfiquer Ali Otty, Naoya Yamazaki, Paolo Bossi, Amarnath Challapalli, Rahul Ladwa, Axel Hauschild, Frank A. Seebach, Suk-Young Yoo, Priscila Hermont Goncalves, Matthew G. Fury. "Phase 3 trial of adjuvant cemiplimab (cemi) versus placebo (pbo) for high-risk cutaneous squamous cell carcinoma (CSCC).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6001